Could a common drug slow vascular dementia?
NCT ID NCT03804229
First seen Apr 06, 2026 · Last updated May 10, 2026 · Updated 5 times
Summary
This phase 3 study tests whether butylphthalide soft capsules can improve thinking, memory, and daily function in people with mild-to-moderate vascular dementia. About 707 participants will receive either the drug or a placebo for one year. The goal is to see if the treatment is safe and effective for managing this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR DEMENTIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuanwu Hospital of Capital Medical University
Beijing, Beijing Municipality, 100053, China
Conditions
Explore the condition pages connected to this study.